Bristol-Myers Squibb will acquire Medarex, a biopharma focused on antibody-based therapeutics for thetreatment life-threatening or debilitating diseases, for $2.4 billion. The dealincludes full ownership of ipilimumab, a melanoma treatment in phase 3, whichBMS called a potentially “important contributor to…future growth,” in a statement.

Digital detailerPhysicians Interactive has acquired Skyscape, a mobile health informationprovider. Skyscape’s user base exceeds one million medical practitioners,according to a release. Terms of the deal were not disclosed.